Fundraising FoxMystic Ventures — 2023 Investments
5 investments dated 2023 · listed companies and verified rows first · show all
Journey Clinical provides ketamine-assisted psychotherapy (KAP) for depression, anxiety, and PTSD, partnering patients with licensed therapists and medical teams while coordinating with major insurance providers.
Digital HealthMedical DevicesMental Health
Jonathan Sabbagh(Founder)inMyriam Barthes(Founder)in
Co-investorsAble PartnersAlleyCorpCoalition OperatorsFifty YearsFJ LabsGaingels+9 more
__Twitter.png)
Psilera is a biotech company developing neuroscience-focused therapeutics, including its lead asset PSIL-006, described as next-generation mindful medicine.
AI & Machine LearningBiotechDeep TechHealthtechMental HealthTampa, US
Jacqueline Lee Salm(Executive Officer)Jackie von Salm(Co-Founder & Chief Scientific Officer)inChris Witowski(Co-Founder & CEO)inScott Rairigh(EVP, Corporate Development)inMagali Haas(Chief Medical Officer)in
Co-investorsBonaventure Equity, LLCIter Investments
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Awakn Life SciencesLykos TherapeuticsNana Health
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.